Latest filing published 22 Nov 2023 for Concord Biotech Limited, €3,405.
Filing timeline
BuySaleUtpal Sheth: trading record in brief
Utpal Sheth is a declared insider of Concord Biotech Limited, with filings sourced from SEBI (PIT + SAST). The record holds 2 filings, for trades running from 13 November 2023 to 20 November 2023.
Purchases make up the whole of the open-market record (2 purchases, €25k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 22 November 2023, reports an open-market purchase of €3,405 in Concord Biotech Limited. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Utpal Sheth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 253 shares@ ₹1,231.023713.6% of flowEquity SharesSEBI:7d5b6426b4fb3fb50e4e416d6a97fb0c565b35faCanonical exit: 18 Feb 2024 (T+90)
- 1,468 shares@ ₹1,319.814786.4% of flowEquity SharesSEBI:547ca22ef8553f6ece3118dc0cb9767ff886d28fCanonical exit: 11 Feb 2024 (T+90)
2 of 2 declarations